Simeon-Dubach D - Search Results

1

Combined treatment with captopril, hydrochlorothiazide and pravastatin in dyslipidemic hypertensive patients.

Waeber B, Greminger P, Riesen W, Darioli R, Simeon-Dubach D, Wunderlin R. Waeber B, et al. Blood Press. 1995 Nov;4(6):358-62. doi: 10.3109/08037059509077621. Blood Press. 1995. PMID: 8746603 Clinical Trial.

2

[Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)].

Koch J, Greminger P, Simeon-Dubach D. Koch J, et al. Praxis (Bern 1994). 1997 Nov 5;86(45):1779-84. Praxis (Bern 1994). 1997. PMID: 9446181 German.

3

[Acute myocardial infarct in Switzerland: results from the PIMICS Heart Infarct Register. PIMICS Project (Prospective Ischemia Myocardial Infarction Captopril Survey)].

Naegeli B, Bertel O, Urban P, Angehrn W, Siegrist P, Stauffer JC, Baumann PC, Jolliet P, Simeon-Dubach D, Meier B, Wunderlin R. Naegeli B, et al. Schweiz Med Wochenschr. 1998 May 9;128(19):729-36. Schweiz Med Wochenschr. 1998. PMID: 9634686 German.

4

ISBER Best Practices for Repositories, Moving Toward the Fifth Edition.

Snapes E, Simeon-Dubach D. Snapes E, et al. Among authors: simeon dubach d. Biopreserv Biobank. 2022 Feb;20(1):107-108. doi: 10.1089/bio.2022.29102.ejs. Biopreserv Biobank. 2022. PMID: 35175836 No abstract available.

5

The Biobank Assessment Tool: Assistance for a Strategic Win in the Battle for Quality.

Bergenstråhle K, Hill K, Simeon-Dubach D. Bergenstråhle K, et al. Among authors: simeon dubach d. Biopreserv Biobank. 2021 Apr;19(2):151-152. doi: 10.1089/bio.2021.29082.kb. Epub 2021 Mar 26. Biopreserv Biobank. 2021. PMID: 33769861 No abstract available.

6

ISBER_UHN Virtual Symposium 2020: Biobank Business Planning Today for a Secure and Sustainable Tomorrow-Workshop Impressions and Lessons Learned.

Henderson MK, Goldring K, Simeon-Dubach D. Henderson MK, et al. Among authors: simeon dubach d. Biopreserv Biobank. 2020 Dec;18(6):594. doi: 10.1089/bio.2020.29079.mkh. Biopreserv Biobank. 2020. PMID: 33320736 Free PMC article. No abstract available.

7

Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom.

Allocca CM, Bledsoe MJ, Albert M, Anisimov SV, Bravo E, Castelhano MG, Cohen Y, De Wilde M, Furuta K, Kozlakidis Z, Martin D, Martins A, McCall S, Morrin H, Pugh RS, Schacter B, Simeon-Dubach D, Snapes E. Allocca CM, et al. Among authors: simeon dubach d. Biopreserv Biobank. 2020 Dec;18(6):533-546. doi: 10.1089/bio.2020.0082. Epub 2020 Nov 6. Biopreserv Biobank. 2020. PMID: 33164554

8

Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.

Simeon-Dubach D, Henderson MK. Simeon-Dubach D, et al. Biopreserv Biobank. 2020 Dec;18(6):503-510. doi: 10.1089/bio.2020.0079. Epub 2020 Oct 8. Biopreserv Biobank. 2020. PMID: 33047969 Free PMC article. Review.

9

ISBER in the Time of COVID.

Seiler CY, Torres A, Simeon-Dubach D. Seiler CY, et al. Among authors: simeon dubach d. Biopreserv Biobank. 2020 Aug;18(4):346-347. doi: 10.1089/bio.2020.29072.cys. Epub 2020 Jul 13. Biopreserv Biobank. 2020. PMID: 32667828 No abstract available.

10

Possible consequences of the COVID-19 pandemic on the use of biospecimens from cancer biobanks for research in academia and bioindustry.

Hofman P, Puchois P, Brest P, Lahlou H, Simeon-Dubach D. Hofman P, et al. Among authors: simeon dubach d. Nat Med. 2020 Jun;26(6):809-810. doi: 10.1038/s41591-020-0890-8. Nat Med. 2020. PMID: 32382152 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page